Dawn Aubel

Dawn Aubel, EdD, MPH, MSN, is Senior Director of Patient Centered Development in AstraZeneca’s Cardiovascular, Renal & Metabolism R&D. A recognized leader in patient-focused drug development, she operationalizes the patient voice through scalable frameworks that align program strategy, clinical trial design, and governance with measurable outcomes. Formerly an advanced nurse practitioner in primary care, Dawn translates real-world patient and family needs into decision-relevant evidence. She has led hundreds of initiatives across the research-to-commercial continuum, built multi-stakeholder alliances, and advanced navigation models that strengthen health systems and access. Her work emphasizes rigorous measurement—defining success criteria, embedding metrics into governance, and linking patient insights to study execution, recruitment performance, and patient-reported outcomes—demonstrating tangible improvements in efficiency, data relevance, and patient satisfaction.